Abstract:Abstract Abstract #6003 Multifunctional nanoparticles with the ability to target tumors, provide molecular imaging and to deliver therapeutic agents hold great promise for improving the survival of cancer patients. We have developed multifunctional nanoparticles targeted to cellular receptors that are highly expressed in breast cancer and tumor stromal cells. Fluorescent quantum dot (QD) or magnetic iron oxide (IO) nanoparticles are conjugated to either the amino-terminal fragment (ATF) of urokinase plasminogen activator (uPA) or to a single chain antibody against the epidermal growth factor receptor (ScFvEGFR), resulting in uPAR or EGFR targeted nanoparticles. Since the binding of ATF peptides or ScFvEGFR to their receptors results in blocking receptor function and internalization of the receptor-ligand complex, these targeted imaging probes can also inhibit tumor growth and deliver drugs. Using near infrared fluorescence (NIR) dye-labeled targeting peptides, we demonstrate specificity of these targeting ligands in an orthotopic human breast cancer model in nude mice. We found that tail vein injection of a mixture of Cy5.5 dye-ATF and IRDye 800-ScFvEGFR peptides leads to the selective accumulation of both probes in human breast cancer xenografts and NIR optical imaging of the tumors in the mammary fat pad of nude mice (Fig. A). We show that uPAR- and EGFR-targeted nanoprobes display different patterns of intratumoral distribution with EGFR probes in the central area and uPAR probes in the peripheral and central regions of the tumor, which may be the results of expressing uPAR in the invasive edge of tumor cells and tumor stromal cells and EGFR only in tumor cells. In vivo optical imaging using ATF-nanoparticles is also demonstrated in human breast cancer xenograft (Fig. B) and in mouse mammary tumor lung metastatic models. Furthermore, magnetic Cy5.5-ATF IO nanoparticles are multimodality imaging probes for both optical and MR tumor imaging. Since magnetic IO nanoparticles are biodegradable and relatively safe for human use, we have developed a therapeutic imaging nanoparticle by encapsulating doxorubicin into the polymer coating of the nanoparticles and have shown selective delivery of the drug and cytotoxic effect in breast cancer cells in vitro. Results of our study show that multifunctional and multiplexed nanoparticles have great potential for the development of novel tumor imaging and therapeutic approaches. Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 6003.

In Situreal-Time Tracing of Hierarchical Targeting Nanostructures in Drug Resistant Tumors Using Diffuse Fluorescence Tomography

In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene- and Photothermal Therapy.

Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy

Construction of a Multifunctional Nano-Scale Metal-Organic Framework-Based Drug Delivery System for Targeted Cancer Therapy

The Royal Society of tracing of hierarchical targeting nanostructures in drug resistant tumors using di ff use fl uorescence tomography †

Intelligent MoS2 Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery to Overcome Cancer Chemotherapy Resistance Guided by PET Imaging

Integrated Prodrug Micelles with Two-Photon Bioimaging and Ph-Triggered Drug Delivery for Cancer Theranostics

A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy.

A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric Prodrug

Nanoparticle-Based Tumor Theranostics with Molecular Imaging

Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality

Near-infrared Light and Tumor Microenvironment Dual Responsive Size-Switchable Nanocapsules for Multimodal Tumor Theranostics

Near-infrared Light-Triggered Size-Shrinkable theranostic nanomicelles for effective tumor targeting and regression

Multistage-responsive clustered nanosystem to improve tumor accumulation and penetration for photothermal/enhanced radiation synergistic therapy

Supramolecular Nano-Tracker for Real-Time Tracking of Drug Release and Efficient Combination Therapy

Self-evolving persistent luminescence nanoprobes for autofluorescence-free ratiometric imaging and on-demand enhanced chemodynamic therapy of pulmonary metastatic tumors

Multifunctional and Multiplexed Nanoparticles for Molecular Imaging and Treatment of Breast Cancer

Microenvironment-Driven Cascaded Responsive Hybrid Carbon Dots as a Multifunctional Theranostic Nanoplatform for Imaging-Traceable Gene Precise Delivery

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

Redox-Activated Light-Up Nanomicelle for Precise Imaging-Guided Cancer Therapy and Real-Time Pharmacokinetic Monitoring

Nanoassembly and Multiscale Computation of Multifunctional Optical-Magnetic Nanoprobes for Tumor-Targeted Theranostics.